Will the COVID-19 outbreak end when the vaccine comes out?



The New York Times (NYT) said on the 12th (local time), "Even if a vaccine is approved, there will be confusion and confusion." "The Americans will have to choose a few'just like that' without knowing which vaccine is best. I can't."



The newspaper predicted that several strains of the first Corona 19 vaccine will be released in the US next spring or summer.



He pointed out that due to the current method of vaccine clinical trials, it is not known which vaccine is relatively superior and that confusion is inevitable.



Currently, COVID-19 vaccine clinical trials are conducted separately for each pharmaceutical company.



Some scientists, including Anthony Pouch, director of the National Institute of Allergy and Infectious Diseases of the U.S., argued for a'mega test' that tests several vaccines at once and compares them with each other. It was not imported.



In the end, it was concluded that'the clinical trials are conducted for each pharmaceutical company, but the procedure is followed by government guidelines, and the National Institutes of Health (NIH) re-enacts the trials for all clinical trial participants.'



In addition, only pharmaceutical companies can utilize NIH's large-scale clinical trial network and receive financial support.



AstraZeneca, Modena, and Johnson & Johnson are participating in the NIH network to conduct clinical trials.



However, Pfizer, who is considered a leader, did not participate.



"Vaccine selection will be difficult," NYT said. "As in other statistical studies, there is a margin of error in clinical trials, so a vaccine that showed '50% effectiveness' in one trial showed '60% effect' in another trial. "It may actually be more effective than the vaccine shown."



There are also concerns that if a vaccine from one pharmaceutical company is approved for use, other vaccine trial participants may quit trying to get the vaccine and the trial could be distorted.



The newspaper said, "We need to prove that the vaccine, which is in the early stages of clinical trials (currently), is better than the approved vaccine, but the difference (between the two vaccines) will be less than the difference between the vaccine and the fake drug. "We have to do clinical trials, and most of the smaller startups trying to improve the vaccine will not be able to afford it."



In addition, it usually takes several years for the vaccine to go to market after three phases of clinical trials.Since the COVID-19 vaccine is actually vaccinated a year or so after the outbreak is reported, there is a possibility that it will be fully recovered if side effects are reported.



(Photo = Getty Image Korea)